{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:47:03Z","timestamp":1774327623146,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["NS117742"],"award-info":[{"award-number":["NS117742"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>23-Hydroxy ursolic acid (23-OH UA) is a potent atheroprotective and anti-obesogenic phytochemical, with anti-inflammatory and inflammation-resolving properties. In this study, we examined whether dietary 23-OH UA protects mice against the acute onset and progression of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Female C57BL\/6 mice were fed either a defined low-calorie maintenance diet (MD) or an MD supplemented with 0.2% wgt\/wgt 23-OH UA for 5 weeks prior to actively inducing EAE and during the 30 days post-immunization. We observed no difference in the onset of EAE between the groups of mice, but ataxia and EAE disease severity were suppressed by 52% and 48%, respectively, and disease incidence was reduced by over 49% in mice that received 23-OH UA in their diet. Furthermore, disease-associated weight loss was strikingly ameliorated in 23-OH UA-fed mice. ELISPOT analysis showed no significant differences in frequencies of T cells producing IL-17 or IFN-\u03b3 between 23-OH UA-fed mice and control mice, suggesting that 23-OH UA does not appear to regulate peripheral T cell responses. In summary, our findings in EAE mice strongly suggest that dietary 23-OH UA may represent an effective oral adjunct therapy for the prevention and treatment of relapsing\u2013remitting MS.<\/jats:p>","DOI":"10.3390\/nu16030348","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T03:59:42Z","timestamp":1706155182000},"page":"348","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dietary Supplementation with 23-Hydroxy Ursolic Acid Reduces the Severity and Incidence of Acute Experimental Autoimmune Encephalomyelitis (EAE) in a Murine Model of Multiple Sclerosis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4619-1610","authenticated-orcid":false,"given":"Reto","family":"Asmis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9306-5783","authenticated-orcid":false,"given":"Megan","family":"Medrano","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0549-3794","authenticated-orcid":false,"given":"Carol","family":"Chase Huizar","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-6103","authenticated-orcid":false,"given":"Wendell","family":"Griffith","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Forsthuber","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"ref_1","first-page":"527","article-title":"Progressive multiple sclerosis: From pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/hmg\/ddl223","article-title":"Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis","volume":"15","author":"Barcellos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"a028951","DOI":"10.1101\/cshperspect.a028951","article-title":"Genetics of Multiple Sclerosis: An Overview and New Directions","volume":"8","author":"Patsopoulos","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1352458517737371","article-title":"Multiple sclerosis genetics","volume":"24","author":"Canto","year":"2018","journal-title":"Mult. Scler."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: Progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp-2011-300616","article-title":"Relative mortality and survival in multiple sclerosis: Findings from British Columbia, Canada","volume":"83","author":"Kingwell","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.0b013e31829a3388","article-title":"Mortality in patients with multiple sclerosis","volume":"81","author":"Scalfari","year":"2013","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.194.5.669","article-title":"A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis","volume":"194","author":"Huseby","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1172\/JCI63842","article-title":"B cell exchange across the blood-brain barrier in multiple sclerosis","volume":"122","author":"Kuo","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","article-title":"B cells and antibodies in multiple sclerosis pathogenesis and therapy","volume":"8","author":"Krumbholz","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/08916934.2012.665523","article-title":"Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis","volume":"45","author":"Mann","year":"2012","journal-title":"Autoimmunity"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.neuro.25.112701.142913","article-title":"Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for Therapy","volume":"25","author":"Steinman","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: A complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: Pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1177\/1352458516643396","article-title":"Astrocytes in multiple sclerosis","volume":"22","author":"Ludwin","year":"2016","journal-title":"Mult. Scler."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1041","DOI":"10.1212\/WNL.0000000000010135","article-title":"Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study","volume":"95","author":"Buron","year":"2020","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/187152712801661284","article-title":"In vitro and in vivo models of multiple sclerosis","volume":"11","author":"Vogel","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/WCO.0b013e328346c226","article-title":"Experimental models of multiple sclerosis","volume":"24","author":"Pachner","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"ref_25","first-page":"e51275","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","volume":"86","author":"Bittner","year":"2014","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10575630290020622","article-title":"Partial synthesis of 23-hydroxyursolic acid isolated from medicinal plants of the Rubiaceae family","volume":"16","author":"Bore","year":"2002","journal-title":"Nat. Prod. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2018.06.882","article-title":"Dietary 23-hydroxy ursolic acid protects against atherosclerosis and obesity by preventing dyslipidemia-induced monocyte priming and dysfunction","volume":"275","author":"Nguyen","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e132527","DOI":"10.1172\/jci.insight.132527","article-title":"TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells","volume":"4","author":"Raphael","year":"2019","journal-title":"JCI Insight"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: Interactions, checks, and balances","volume":"20","author":"Li","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41582-019-0253-6","article-title":"When encephalitogenic T cells collaborate with microglia in multiple sclerosis","volume":"15","author":"Dong","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","article-title":"The search for the target antigens of multiple sclerosis, part 1: Autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ahn, Y.J., Wang, L., Foster, S., and Asmis, R. (2020). Dietary 23-hydroxy ursolic acid protects against diet-induced weight gain and hyperglycemia by protecting monocytes and macrophages against nutrient stress-triggered reprogramming and dysfunction and preventing adipose tissue inflammation. J. Nutr. Biochem., 86.","DOI":"10.1016\/j.jnutbio.2020.108483"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0022-510X(83)90167-3","article-title":"Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis","volume":"61","author":"Epstein","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0171-2985(96)80024-6","article-title":"Macrophages in multiple sclerosis","volume":"195","author":"Bruck","year":"1996","journal-title":"Immunobiology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnen\/nlab083","article-title":"Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination","volume":"80","author":"Prineas","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.2000208117","article-title":"A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fneur.2015.00180","article-title":"The Role of Astrocytes in Multiple Sclerosis Progression","volume":"6","author":"Correale","year":"2015","journal-title":"Front. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00281-015-0515-3","article-title":"Control of autoimmune CNS inflammation by astrocytes","volume":"37","author":"Rothhammer","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.1615413114","article-title":"Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation","volume":"114","author":"Rothhammer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-019-1524-2","article-title":"An update on reactive astrocytes in chronic pain","volume":"16","author":"Li","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34223","DOI":"10.1038\/srep34223","article-title":"Monocytic MKP-1 is a Sensor of the Metabolic Environment and Regulates Function and Phenotypic Fate of Monocyte-Derived Macrophages in Atherosclerosis","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E2803","DOI":"10.1073\/pnas.1212596109","article-title":"Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/3\/348\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:48:56Z","timestamp":1760104136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/3\/348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["nu16030348"],"URL":"https:\/\/doi.org\/10.3390\/nu16030348","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]}}}